John Haanen
MD, PhD
Head, Division of Medical Oncology
👥Biography 个人简介
Dr. John Haanen is one of Europe's leading cancer immunotherapists and has been a principal investigator in European TIL therapy trials including pivotal studies of lifileucel. His group at the Netherlands Cancer Institute has contributed to neoantigen-reactive TIL selection and manufacturing improvements. He has helped bridge NCI-derived TIL protocols to commercial manufacturing and regulatory approval in Europe.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 John Haanen 的研究动态
Follow John Haanen's research updates
留下邮箱，当我们发布与 John Haanen（Netherlands Cancer Institute）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment